PAINWeekEnd Philadelphia is scheduled to take place October 26 at the DoubleTree by Hilton Hotel and will offer 6.0 hours of continuing medical education in the management of chronic pain.
The curriculum to be presented at PAINWeekEnd Philadelphia will equip participants with knowledge and skills to better negotiate the changing regulatory landscape for prescribers while meeting the needs of their patients with pain, according to Global Education Group in a media release.
Senior PAINWeek faculty member Kevin Zacharoff, MD, FACPE, FACIP, FAAP, will lead an examination of the role of illicit substances in the overdose epidemic in his course, “The Other Opioid Crisis: Heroin and Fentanyl.”
He will also present a course titled, “The Regulatory Agency Will See You Now,” which will present and detail the variety of current regulatory forces that need to be considered in clinical practice; how they can potentially impact clinical decisions regarding chronic pain; and how they can be negotiated.
Other course topics to be offered at PAINWeekEnd Philadelphia include: “Bridges to Babylon: Assessing & Managing Comorbidities in Chronic Pain Patients” “3’s Company: COX-2 Inhibitors, Medicinal Marijuana, and Opioid Prescribing” “Do As I Say! Facilitating Treatment Adherence in Pain Medicine”; and “To Dream the Impossible Dream: Acute Pain Management for Patients on Buprenorphine.”
Commercially supported activities—addressing a range of product, disease state, and medical information topics—will also be presented, per the release.
For more information and to register, visit PainWeek.
[Source(s): Global Education Group, PRWeb]
